Itamar Medical Ltd. ITMR
Apr 24, 2025, 3:47 PM EDT
52-week range unavailable
- Market cap
- 506.91M
- Revenue (ttm)
- 50.88M
- Profit margin
- -41.65%
- Shares out
- 16.42M
- Forward P/E
- -61.74
- Volume
- 1.02M
- Open
- 30.80
- Previous close
- 30.87
- Day's range
- 30.75 – 30.91
- Beta
- 0.54
- Analysts
- Hold
- Price target
- 30.75 (-0.4%)
- Earnings date
- Nov 18, 2021
Key statistics
- Enterprise value
- 448.80M
- PEG ratio
- 0.00
- Price / sales
- 9.96
- Price / book
- 6.86
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 23.30%
- Free cash flow
- -7.44M
- Total cash
- 68.65M
- Total debt
- 10.85M
- Return on equity
- -35.33%
- Short % of float
- 0.00%
- 50-day average
- 30.57
- 200-day average
- 24.64
Analyst view
Consensus: hold
- Target (low)
- 30.00
- Target (mean)
- 30.75
- Target (high)
- 31.00
- Strong buy0
- Buy1
- Hold4
- Sell0
- Strong sell0
Next earnings
Nov 18, 2021
Expected Nov 18, 2021. Consensus EPS estimate -0.27.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 18, 2021 | Sep 1, 2021 | -0.30 | — | — | — |
| Aug 10, 2021 | Jun 1, 2021 | -0.30 | — | — | — |
| May 19, 2021 | Mar 1, 2021 | -0.20 | — | — | — |
| Mar 2, 2021 | Dec 1, 2020 | -0.14 | — | — | — |
| Nov 17, 2020 | Sep 1, 2020 | -0.17 | — | — | — |
| Aug 11, 2020 | Jun 1, 2020 | -0.19 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 20, 2021 | SVB Leerink | down | Outperform | Market Perform |
| Sep 15, 2021 | Ladenburg Thalmann | down | Buy | Neutral |
| Sep 14, 2021 | HC Wainwright & Co. | down | Buy | Neutral |
| Sep 14, 2021 | Cowen & Co. | down | Outperform | Market Perform |
| May 20, 2021 | SVB Leerink | main | — | Outperform |
| Mar 8, 2021 | HC Wainwright & Co. | main | — | Buy |
About Itamar Medical Ltd.
Itamar Medical Ltd., a medical technology company, develops and commercializes non-invasive medical devices and solutions for the treatment of respiratory sleep disorders. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enable to conduct home sleep apnea tests for the treatment of sleep apnea, such as obstructive sleep apnea; EndoPAT device that diagnoses endothelial dysfunction; and Loop device, a wrist device for measuring and recording physiological parameters, such as SpO2, respiration rate, and heart rate. The company operates in the United States, Canada, Europe, Israel, Japan, rest of the Asia Pacific, and internationally. The company was formerly known as Itamar Medical (CM) 1997 Ltd. and changed its name to Itamar Medical Ltd. in July 2000. Itamar Medical Ltd. was incorporated in 1997 and is headquartered in Caesarea, Israel. As of December 16, 2021, Itamar Medical Ltd. operates as a subsidiary of ZOLL Medical Corporation.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- Israel
- Website
- itamar-medical.com
News
Itamar Medical Ltd. Sponsored ADR (ITMR) Reports Q3 Loss, Lags Revenue Estimates 
Analysts Estimate Itamar Medical Ltd. Sponsored ADR (ITMR) to Report a Decline in Earnings: What to Look Out for 
72 Biggest Movers From Yesterday 
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Merger of Itamar Medical Ltd. with ZOLL Medical Corporation 
Mid-Afternoon Market Update: Dow Rises Over 100 Points; Itamar Medical Shares Spike Higher 
ITMR Stock: The $538M Reason Why Itamar Medical Is Soaring 45% on Monday - Mid-Day Market Update: Crude Oil Up 1%; MiMedx Group Shares Plummet
45 Stocks Moving In Monday's Mid-Day Session 
Why Itamar Medical Stock Is Skyrocketing Today 
Mid-Morning Market Update: Markets Mixed; UK Terminates Valneva's COVID-19 Vaccine Contract
Your note
Sign in to keep a note on ITMR — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 4.23% | 694,667 | 20.99M | Sep 29, 2021 |
| First Light Asset Management, LLC | 4.04% | 662,969 | 20.03M | Sep 29, 2021 |
| Federated Hermes, Inc. | 3.05% | 500,000 | 15.11M | Sep 29, 2021 |
| JP Morgan Chase & Company | 2.69% | 441,136 | 13.33M | Sep 29, 2021 |
| AllianceBernstein, L.P. | 2.63% | 432,067 | 13.06M | Sep 29, 2021 |
| First Trust Capital Management L.P. | 2.60% | 426,635 | 12.89M | Sep 29, 2021 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Federated Hermes Kaufmann Small Cap Fund | 3.05% | 500,000 | 9.86M | Jul 30, 2021 |
| First Tr Exchange Traded Fd-First Trust Merger Arbitrage Fd | 2.56% | 420,704 | 12.71M | Sep 29, 2021 |
| Calamos Timpani Small Cap Growth Fund | 0.93% | 151,988 | 3.00M | Jul 30, 2021 |
| Brinker Capital Destinations Tr-Destinations Multi Strategy Alt Fd | 0.33% | 54,523 | 1.16M | Aug 30, 2021 |
| EQ Advisors Trust-1290 VT Gamco Mergers & Acquisitions Port | 0.25% | 41,000 | 1.24M | Sep 29, 2021 |
| Pace Select Advisors Tr-Pace Small/Medium Co Growth Equity Investments | 0.25% | 40,471 | 798.09K | Jul 30, 2021 |